Literature DB >> 626551

Systemic factors contributory to retinal vein occlusion.

M A McGrath, F Wechsler, A B Hunyor, R Penny.   

Abstract

This study was undertaken in 79 patients with retinal vein occlusion to assess the different systemic mechanisms contributing to the occlusion, namely, intrinsic vessel disease and abnormalities of the blood constituents and blood viscosity. In 55 patients older than 50 years of age, important associations were hypertension, abnormal results on glucose tolerance test, hyperlipidemia, chronic lung disease, and elevated serum IgA levels. In the 24 patients younger than 50 years of age, male incidence was high and important associations were head injuries, hyperlipidemia, and the use of estrogen-containing preparations. Hyperviscosity and cryofibrinogenemia were prominent in both groups. The pathogenesis of retinal venous occlusion is complex involving interaction between the vessel wall and blood constituents.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 626551

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  29 in total

1.  Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.

Authors:  C Hvarfner; A Hillarp; J Larsson
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

Authors:  Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Michael S Ip; Barbara A Blodi; Mary Elizabeth Hartnett; Geoff Cohen
Journal:  Ophthalmology       Date:  2011-02       Impact factor: 12.079

3.  Thrombus and branch retinal vein occlusion.

Authors:  E Baglivo; A Dosso; C Pournaras
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-01       Impact factor: 3.117

Review 4.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

5.  Haemorheology in patients with branch retinal vein occlusion with and without risk factors.

Authors:  A Remky; O Arend; F Jung; H Kiesewetter; M Reim; S Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

6.  Activated protein C resistance in central retinal vein occlusion.

Authors:  G Sanborn
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

7.  A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution.

Authors:  L L Hansen; J Wiek; M Wiederholt
Journal:  Br J Ophthalmol       Date:  1989-11       Impact factor: 4.638

8.  Activated protein C resistance in patients with central retinal vein occlusion.

Authors:  J Larsson; A Sellman; B Bauer
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

9.  Combined central retinal artery-central vein obstruction.

Authors:  G C Brown; J S Duker; R Lehman; R C Eagle
Journal:  Int Ophthalmol       Date:  1993-02       Impact factor: 2.031

10.  Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion.

Authors:  G E Trope; G D Lowe; B M McArdle; J T Douglas; C D Forbes; C M Prentice; W S Foulds
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.